Clinical evaluation of a (1,3)-beta-D-glucan assay for presumptive diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients.
about
High Levels of beta-D-glucan in immunocompromised children with proven invasive fungal disease.Thymopoietic and bone marrow response to murine Pneumocystis pneumonia.Serum (1->3)-beta-D-glucan levels in primary infection and pulmonary colonization with Pneumocystis jirovecii.Clinical performance of the (1,3)-β-D-glucan assay in early diagnosis of nosocomial Candida bloodstream infections.Pneumocystis jirovecii infection: Cell wall (1→3)-β-D-glucan biology and diagnostic utility.Occurrence, presentation and treatment of candidemia.Pneumocystis pneumonia during Postoperative Adjuvant Chemotherapy for Breast Cancer.Elevated serum beta-D-glucan levels in immunocompromised children with clinical suspicion for Pneumocystis jirovecii pneumoniaSerum (1->3)-{beta}-D-Glucan assay for the diagnosis of Pneumocystis jiroveci pneumonia.Use of 1,3-β-D-glucan in invasive fungal diseases in hematology patients.
P2860
Q33825648-E3F85CA1-9EF2-4864-8AA9-EA7A387DDAA2Q34931539-D34D345B-1366-4D4C-B3F7-097425520088Q35066665-1961F784-CB91-4C75-A121-6B5AD2B65393Q35598171-CE534738-F4E6-43FD-8F72-B8883BB1F7E4Q37790390-F65BC840-3547-4706-964F-F519D664CA92Q38061190-14138751-DEAD-4FF7-A1A5-E2173EB54012Q40244622-70A75955-E2A4-4533-8AE8-141B47084584Q42849189-7A1C11D9-786B-4A70-A221-E680CCE6DC7BQ42929833-29799D6A-C78A-48CB-95E3-5102E75EAB6DQ50072321-9522361F-9233-441F-B23B-BF7158C1ED38
P2860
Clinical evaluation of a (1,3)-beta-D-glucan assay for presumptive diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Clinical evaluation of a (1,3) ...... in immunocompromised patients.
@en
Clinical evaluation of a (1,3) ...... in immunocompromised patients.
@nl
type
label
Clinical evaluation of a (1,3) ...... in immunocompromised patients.
@en
Clinical evaluation of a (1,3) ...... in immunocompromised patients.
@nl
prefLabel
Clinical evaluation of a (1,3) ...... in immunocompromised patients.
@en
Clinical evaluation of a (1,3) ...... in immunocompromised patients.
@nl
P2093
P2860
P356
P1476
Clinical evaluation of a (1,3) ...... in immunocompromised patients
@en
P2093
Alessandra Mularoni
Claudio Viscoli
Elisa Furfaro
Emanuele Delfino
Franca Miletich
Valerio Del Bono
P2860
P304
P356
10.1128/CVI.00276-09
P577
2009-08-19T00:00:00Z